Navigation Links
Landauer Names Douglas R. Gipson Chief Nuclear Executive
Date:5/29/2009

GLENWOOD, Ill., May 29 /PRNewswire-FirstCall/ -- Landauer, Inc. (NYSE: LDR) announced today that Douglas R. Gipson has been named Chief Nuclear Executive, effective May 15, 2009. Gipson will assume overall responsibility for Landauer's Global Nuclear Power Business. "We are very pleased to be able to name Doug to this critical position for Landauer. He has extensive industry experience at the executive and operating level and will be integral to Landauer's global nuclear power strategy. Doug is a tremendous addition to the Landauer management team," said Bill Saxelby, President and Chief Executive Officer.

Mr. Gipson is the recently retired Executive Vice President, Power Generation and Chief Nuclear Officer of Detroit Edison, a subsidiary of DTE Energy. Mr. Gipson was responsible for all of Detroit Edison's fossil and nuclear power generation facilities. His corporate duties further extended to responsibility for both DTE's industrial safety program and its environmental affairs, which included management of the environmental engineering and construction unit. In addition to his new role with Landauer, Gipson is currently the Chief Executive Officer of GenCo Asset Alliance. GenCo is a new company designed to meet the current large electrical motor needs of the utility sector. Additionally, Mr. Gipson is an Executive Consultant to URS/Washington Group's Nuclear Operations Power Business Unit. URS is working with several utilities and industry leading companies to develop the next generation of nuclear power plants.

In addition to his long tenure as DTE's Chief Nuclear Officer, Mr. Gipson combines a thorough understanding of nuclear technology and process with business and industry acumen. He has provided leadership and been an active voice in the U.S. nuclear industry, with extensive committee and board participation in professional organizations and universities, among them the American Nuclear Society, Nuclear Energy Institute, Institute of Nuclear Power Operations, Electric Power Research Institute, the Utilities Service Alliance, the Nuclear Management and Resources Council, and the University of Michigan.

Bill Saxelby continued, "This new position reflects the commitment and consistent execution against our long-term strategic plan, which focuses on: optimizing the core business, driving competitive growth and pursuing strategic expansion. Doug Gipson has 40 years of nuclear power experience in operating and executive management roles - his experience will be a significant asset relative to competitive growth and strategic expansion opportunities going forward. We are excited about having Doug strengthen our senior management team and are looking forward to his contribution."

About Landauer

Landauer is the leading provider of analytical services to determine occupational and environmental radiation exposure. For more than 50 years, the Company has provided complete radiation dosimetry services to hospitals, medical and dental offices, universities, national laboratories, and other industries in which radiation poses a potential threat to employees. Landauer's services include the manufacture of various types of radiation detection monitors, the distribution and collection of the monitors to and from clients, and the analysis and reporting of exposure findings.


'/>"/>
SOURCE Landauer, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Air Products Sells Three U.S. Healthcare Businesses to Landauer-Metropolitan
2. Landauer, Inc. Sets Date and Time for Announcement of Fiscal Second Quarter 2009 Results
3. Landauer, Inc. Declares Regular Cash Dividend
4. Landauer, Inc. Sets Date and Time for Announcement of Fiscal First Quarter 2009 Results
5. Landauer, Inc. Increases Regular Cash Dividend and Declares First Quarter Payment
6. Landauer, Inc. Sets Date and Time for Announcement of Fiscal Fourth Quarter and Full Year 2008 Results
7. Landauer, Inc. Declares Regular Cash Dividend
8. Landauer, Inc. Declares Regular Cash Dividend
9. Landauer, Inc. Reports Record Results for Second Quarter
10. Landauer, Inc. Declares Regular Cash Dividend
11. Landauer, Inc. Reports Strong Fiscal 2008 First Quarter Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... Australia (PRWEB) , ... February 24, 2017 , ... The ... AU) offers Erik Schanssema ’s true account of his paramedic experiences. Schanssema describes ... stress disorder and his attempts to overcome them. , Schanssema, initially unsure of ...
(Date:2/24/2017)... (PRWEB) , ... February 24, 2017 , ... Yisrayl Hawkins, ... focuses on Bible Prophecy concerning this present generation. Yisrayl makes an astounding statement ... current generation. He explains that the Bible details the current times so plainly ...
(Date:2/24/2017)... ... 24, 2017 , ... The Radiology Business Management Association will select ... the annual Building Better Radiology Marketing Programs conference, held this year from ... Texas. Nine awards are given out in five categories. They are:, ...
(Date:2/24/2017)... ... 2017 , ... Castle Farms, the celebrated Northern Michigan ... the winning couple announced on Feb. 14, 2017, on Facebook. The free wedding ... A Matter of Taste, Ryan Rousseau Enterprises, A Touch of Spring and Other ...
(Date:2/23/2017)... , ... February 23, 2017 , ... The 89th Academy ... winner of the 2016 National Education Policy Center Bunkum Award. We invite you to ... 2016. , This year’s Bunkum winner is the Center for American Progress (CAP), for ...
Breaking Medicine News(10 mins):
(Date:2/24/2017)... 2017 Research and Markets has announced the ... - 2016" report to their offering. ... The latest research Urinary Incontinence Drugs ... benchmarks in the global Urinary Incontinence market. The research answers ... key drugs marketed for Urinary Incontinence and their clinical attributes? How ...
(Date:2/23/2017)... Research and Markets has announced the addition of the ... report to their offering. ... The latest research Autism Spectrum Disorder Drugs Price Analysis ... the global Autism Spectrum Disorder market. The research answers the ... drugs marketed for Autism Spectrum Disorder and their clinical attributes? How ...
(Date:2/23/2017)... , Südkorea, 23. Februar 2017 LG ... für Sterilisationsaufgaben vorgestellt. Die Sterilisationsleistung beträgt das 1,5-fache des ... ultraviolette Strahlung im Bereich zwischen 200 und 280 nm und ... von Bakterien, indem es ihre DNA zerstört. Das Produkt ... ...
Breaking Medicine Technology: